APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C1 Esterase Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C1 Esterase Inhibitors Industry Growth and Trends Forecast to 2032

Report ID 173973510128 December 202579 pages

Choose your research edition.

Industry ResearchC1 Esterase Inhibitors Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal C1 Esterase Inhibitors Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal C1 Esterase Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1 Esterase Inhibitors Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal C1 Esterase Inhibitors Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global C1 Esterase Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C1 Esterase Inhibitors include Takeda, Pharming Healthcare and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C1 Esterase Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C1 Esterase Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C1 Esterase Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C1 Esterase Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global C1 Esterase Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C1 Esterase Inhibitors Market by Company

Takeda

Pharming Healthcare

CSL Behring

C1 Esterase Inhibitors Segment by Type

Recombinant C1-INH

Plasma-derived C1-INH

C1 Esterase Inhibitors Segment by Application

Hospital and Clinic

Pharmacy

Other

C1 Esterase Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1 Esterase Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1 Esterase Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1 Esterase Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C1 Esterase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of C1 Esterase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant C1-INH Table 2. Major Company of Plasma-derived C1-INH Table 3. Global C1 Esterase Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 5. Global C1 Esterase Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global C1 Esterase Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global C1 Esterase Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 9. Global C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 10. Global C1 Esterase Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global C1 Esterase Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global C1 Esterase Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global C1 Esterase Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 14. North America C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 15. North America C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. Europe C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Latin America C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa C1 Esterase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. C1 Esterase Inhibitors Industry Trends Table 25. C1 Esterase Inhibitors Industry Drivers Table 26. C1 Esterase Inhibitors Industry Opportunities and Challenges Table 27. C1 Esterase Inhibitors Industry Restraints Table 28. Global C1 Esterase Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global C1 Esterase Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global C1 Esterase Inhibitors Sales by Company (2021-2026) & (K Units) Table 31. Global C1 Esterase Inhibitors Sales Share by Company (2021-2026) Table 32. Global C1 Esterase Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global C1 Esterase Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global C1 Esterase Inhibitors Major Company Production Sites and Headquarters Table 35. Global C1 Esterase Inhibitors Company, Product Type & Application Table 36. Global C1 Esterase Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global C1 Esterase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global C1 Esterase Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global C1 Esterase Inhibitors Sales by Region (2021-2026) & (K Units) Table 41. Global C1 Esterase Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global C1 Esterase Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global C1 Esterase Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global C1 Esterase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global C1 Esterase Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global C1 Esterase Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global C1 Esterase Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global C1 Esterase Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global C1 Esterase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global C1 Esterase Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global C1 Esterase Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global C1 Esterase Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global C1 Esterase Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 57. Global C1 Esterase Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global C1 Esterase Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global C1 Esterase Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global C1 Esterase Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 61. North America C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 62. North America C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. Europe C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Latin America C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa C1 Esterase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Takeda C1 Esterase Inhibitors Product Portfolio Table 75. Takeda Recent Development Table 76. Pharming Healthcare Company Information Table 77. Pharming Healthcare Business Overview Table 78. Pharming Healthcare C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pharming Healthcare C1 Esterase Inhibitors Product Portfolio Table 80. Pharming Healthcare Recent Development Table 81. CSL Behring Company Information Table 82. CSL Behring Business Overview Table 83. CSL Behring C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CSL Behring C1 Esterase Inhibitors Product Portfolio Table 85. CSL Behring Recent Development Table 86. North America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 88. North America C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 89. North America C1 Esterase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America C1 Esterase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 91. North America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America C1 Esterase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 93. North America C1 Esterase Inhibitors Market Share by Country (2021-2026) Table 94. North America C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America C1 Esterase Inhibitors Market Share Forecast by Country (2027-2032) Table 96. Europe C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 98. Europe C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 99. Europe C1 Esterase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe C1 Esterase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 101. Europe C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe C1 Esterase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe C1 Esterase Inhibitors Market Share by Country (2021-2026) Table 104. Europe C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe C1 Esterase Inhibitors Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific C1 Esterase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific C1 Esterase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific C1 Esterase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific C1 Esterase Inhibitors Market Share by Country (2021-2026) Table 114. Asia-Pacific C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific C1 Esterase Inhibitors Market Share Forecast by Country (2027-2032) Table 116. Latin America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 118. Latin America C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 119. Latin America C1 Esterase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America C1 Esterase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America C1 Esterase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America C1 Esterase Inhibitors Market Share by Country (2021-2026) Table 124. Latin America C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America C1 Esterase Inhibitors Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa C1 Esterase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa C1 Esterase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa C1 Esterase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa C1 Esterase Inhibitors Market Share by Country (2021-2026) Table 134. Middle East and Africa C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa C1 Esterase Inhibitors Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. C1 Esterase Inhibitors Distributors List Table 139. C1 Esterase Inhibitors Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. C1 Esterase Inhibitors Image Figure 2. Global C1 Esterase Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C1 Esterase Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global C1 Esterase Inhibitors Sales (2021-2032) & (K Units) Figure 5. Recombinant C1-INH Image Figure 6. Global Recombinant C1-INH Sales YoY Growth (2021-2032) & (K Units) Figure 7. Plasma-derived C1-INH Image Figure 8. Global Plasma-derived C1-INH Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global C1 Esterase Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global C1 Esterase Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America C1 Esterase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America C1 Esterase Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe C1 Esterase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe C1 Esterase Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific C1 Esterase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific C1 Esterase Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America C1 Esterase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America C1 Esterase Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa C1 Esterase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa C1 Esterase Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 C1 Esterase Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global C1 Esterase Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global C1 Esterase Inhibitors Market Share by Application 2025 VS 2032 Figure 31. North America C1 Esterase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 32. North America C1 Esterase Inhibitors Sales Market Share in Value by Application in 2025 Figure 33. Europe C1 Esterase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. Europe C1 Esterase Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific C1 Esterase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific C1 Esterase Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Latin America C1 Esterase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Latin America C1 Esterase Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa C1 Esterase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa C1 Esterase Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. North America C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America C1 Esterase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America C1 Esterase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America C1 Esterase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe C1 Esterase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe C1 Esterase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe C1 Esterase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific C1 Esterase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific C1 Esterase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific C1 Esterase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America C1 Esterase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America C1 Esterase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America C1 Esterase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa C1 Esterase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa C1 Esterase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa C1 Esterase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. C1 Esterase Inhibitors Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. C1 Esterase Inhibitors Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant C1-INH
  • Plasma-derived C1-INH
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Pharming Healthcare
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C1 Esterase Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global C1 Esterase Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 C1 Esterase Inhibitors Market by Type
  6. 1.3.1 Recombinant C1-INH
  7. 1.3.2 Plasma-derived C1-INH
  8. 1.4 Global C1 Esterase Inhibitors Market Size by Type
  9. 1.4.1 Global C1 Esterase Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global C1 Esterase Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global C1 Esterase Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America C1 Esterase Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe C1 Esterase Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific C1 Esterase Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America C1 Esterase Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa C1 Esterase Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 C1 Esterase Inhibitors Industry Trends
  2. 2.2 C1 Esterase Inhibitors Industry Drivers
  3. 2.3 C1 Esterase Inhibitors Industry Opportunities and Challenges
  4. 2.4 C1 Esterase Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by C1 Esterase Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by C1 Esterase Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by C1 Esterase Inhibitors Price (2021-2026)
  4. 3.4 Global C1 Esterase Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C1 Esterase Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global C1 Esterase Inhibitors Company, Product Type & Application
  7. 3.7 Global C1 Esterase Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C1 Esterase Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C1 Esterase Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C1 Esterase Inhibitors Tier 1, Tier 2, and Tier 3
4 C1 Esterase Inhibitors Regional Status and Outlook
  1. 4.1 Global C1 Esterase Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global C1 Esterase Inhibitors Historic Market Size by Region
  3. 4.2.1 Global C1 Esterase Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global C1 Esterase Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global C1 Esterase Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global C1 Esterase Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global C1 Esterase Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global C1 Esterase Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global C1 Esterase Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 C1 Esterase Inhibitors by Application
  1. 5.1 C1 Esterase Inhibitors Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global C1 Esterase Inhibitors Market Size by Application
  6. 5.2.1 Global C1 Esterase Inhibitors Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global C1 Esterase Inhibitors Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global C1 Esterase Inhibitors Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America C1 Esterase Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe C1 Esterase Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific C1 Esterase Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America C1 Esterase Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa C1 Esterase Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda C1 Esterase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda C1 Esterase Inhibitors Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Pharming Healthcare
  8. 6.2.1 Pharming Healthcare Company Information
  9. 6.2.2 Pharming Healthcare Business Overview
  10. 6.2.3 Pharming Healthcare C1 Esterase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pharming Healthcare C1 Esterase Inhibitors Product Portfolio
  12. 6.2.5 Pharming Healthcare Recent Developments
  13. 6.3 CSL Behring
  14. 6.3.1 CSL Behring Company Information
  15. 6.3.2 CSL Behring Business Overview
  16. 6.3.3 CSL Behring C1 Esterase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Behring C1 Esterase Inhibitors Product Portfolio
  18. 6.3.5 CSL Behring Recent Developments
7 North America by Country
  1. 7.1 North America C1 Esterase Inhibitors Sales by Country
  2. 7.1.1 North America C1 Esterase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America C1 Esterase Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America C1 Esterase Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America C1 Esterase Inhibitors Market Size by Country
  6. 7.2.1 North America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America C1 Esterase Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe C1 Esterase Inhibitors Sales by Country
  2. 8.1.1 Europe C1 Esterase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe C1 Esterase Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe C1 Esterase Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe C1 Esterase Inhibitors Market Size by Country
  6. 8.2.1 Europe C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe C1 Esterase Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific C1 Esterase Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific C1 Esterase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific C1 Esterase Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific C1 Esterase Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific C1 Esterase Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific C1 Esterase Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America C1 Esterase Inhibitors Sales by Country
  2. 10.1.1 South America C1 Esterase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America C1 Esterase Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America C1 Esterase Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America C1 Esterase Inhibitors Market Size by Country
  6. 10.2.1 South America C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America C1 Esterase Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa C1 Esterase Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa C1 Esterase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa C1 Esterase Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa C1 Esterase Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa C1 Esterase Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa C1 Esterase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa C1 Esterase Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa C1 Esterase Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 C1 Esterase Inhibitors Value Chain Analysis
  2. 12.1.1 C1 Esterase Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 C1 Esterase Inhibitors Production Mode & Process
  7. 12.2 C1 Esterase Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 C1 Esterase Inhibitors Distributors
  10. 12.2.3 C1 Esterase Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst